Literature DB >> 25459282

High-resolution MR imaging of the arterial wall in moyamoya disease.

Min Yuan1, Zhi-qiang Liu1, Zhi-qiang Wang2, Bin Li1, Li-jun Xu3, Xin-lan Xiao4.   

Abstract

High resolution magnetic resonance imaging (HRMRI) has been developed as an emerging tool for evaluating intracranial arterial disease. We aimed to analyze the progression of diseased arterial walls in moyamoya disease (MMD) and further elucidate differences compared to intracranial atherosclerotic stenosis using HRMRI. The population of this HRMRI study consisted of 21 patients with MMD and 44 patients with atherosclerotic middle cerebral artery (MCA) stenosis. The cross-sectional images of the MCA wall on HRMRI were compared between the two groups based on outer diameter, wall thickness, luminal stenotic morphology, signal intensity, collateral vascular structures adjacent to stenotic position. In addition, stage classification based on MRA finding was used to depict the course of moyamoya disease. We compared outer diameter and wall thickness of the MCAs in different MRA stages. As a result, the outer diameter and wall thickness of MCAs were significantly smaller in the MMD group than in the atherosclerosis group (outer diameter: MMD 2.01 ± 0.31 mm vs. atherosclerosis 3.31 ± 0.37 mm, p<0.001 and wall thickness: MMD 0.39 ± 0.19 mm vs. atherosclerosis 1.64 ± 0.38 mm, p < 0.001). The concentric stenosis (91.4% in MMD vs. 36.9% in atherosclerosis group, p < 0.001), homogeneous signal intensity (85.7% in MMD vs. 32.6% in atherosclerosis group, p < 0.001) and collateral vascular structures (54.3% in MMD vs. 8.7% in atherosclerosis group, p < 0.001) were more common in MMD patients. In addition, the outer diameter of MCAs in MMD was significantly different between MRA stage 1 and MRA stage 3 or 4 (MRA stage 1 vs. MRA stage 3, Nemenyi test p = 0.005 and MRA stage 1 vs. MRA stage 4, Nemenyi test p = 0.009). But the wall thickness of MCAs was no significantly different in different MRA stages (Kruskal-wallis H test, p = 0.074). We conclude that HRMRI may be used to identify different types of middle cerebral artery stenosis. MMD was characterized by concentric stenosis, homogeneous signal intensity, and collateral vascular structures in the affected MCA segments by HRMRI. Pathological shrinkage of MCA was an important phenomenon in MMD progression.
Copyright © 2014. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Arterial wall; Atherosclerosis; HRMRI; Moyamoya disease

Mesh:

Year:  2014        PMID: 25459282     DOI: 10.1016/j.neulet.2014.10.021

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  24 in total

1.  Added Value of Vessel Wall Magnetic Resonance Imaging in the Differentiation of Moyamoya Vasculopathies in a Non-Asian Cohort.

Authors:  Mahmud Mossa-Basha; Adam de Havenon; Kyra J Becker; Danial K Hallam; Michael R Levitt; Wendy A Cohen; Daniel S Hippe; Matthew D Alexander; David L Tirschwell; Thomas Hatsukami; Catherine Amlie-Lefond; Chun Yuan
Journal:  Stroke       Date:  2016-06-07       Impact factor: 7.914

Review 2.  Vessel Wall Imaging of Cerebrovascular Disorders.

Authors:  Kyle C Kern; David S Liebeskind
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-11-14

Review 3.  Current Clinical Applications of Intracranial Vessel Wall MR Imaging.

Authors:  Raghav R Mattay; Jose F Saucedo; Vance T Lehman; Jiayu Xiao; Emmanuel C Obusez; Scott B Raymond; Zhaoyang Fan; Jae W Song
Journal:  Semin Ultrasound CT MR       Date:  2021-08-01       Impact factor: 1.641

Review 4.  7T MRI for Intracranial Vessel Wall Lesions and Its Associated Neurological Disorders: A Systematic Review.

Authors:  Chen Zhang; Jiong Shi
Journal:  Brain Sci       Date:  2022-04-21

5.  Spontaneous and Unruptured Chronic Intracranial Artery Dissection : High-resolution Magnetic Resonance Imaging Findings.

Authors:  Seung Chai Jung; Ho Sung Kim; Choong-Gon Choi; Sang Joon Kim; Sun U Kwon; Dong-Wha Kang; Jong S Kim
Journal:  Clin Neuroradiol       Date:  2016-09-27       Impact factor: 3.649

6.  Vessel Wall and Lumen Features in North American Moyamoya Patients.

Authors:  Petrice M Cogswell; Sarah K Lants; L Taylor Davis; Meher R Juttukonda; Matthew R Fusco; Manus J Donahue
Journal:  Clin Neuroradiol       Date:  2019-08-06       Impact factor: 3.649

7.  Vessel Wall Thickening and Enhancement in High-Resolution Intracranial Vessel Wall Imaging: A Predictor of Future Ischemic Events in Moyamoya Disease.

Authors:  A Kathuveetil; P N Sylaja; S Senthilvelan; C Kesavadas; M Banerjee; B Jayanand Sudhir
Journal:  AJNR Am J Neuroradiol       Date:  2020-01-02       Impact factor: 3.825

Review 8.  High-resolution Magnetic Resonance Vessel Wall Imaging for Intracranial Arterial Stenosis.

Authors:  Xian-Jin Zhu; Wu Wang; Zun-Jing Liu
Journal:  Chin Med J (Engl)       Date:  2016-06-05       Impact factor: 2.628

Review 9.  The Pathophysiology of Moyamoya Disease: An Update.

Authors:  Oh Young Bang; Miki Fujimura; Seung-Ki Kim
Journal:  J Stroke       Date:  2016-01-29       Impact factor: 6.967

Review 10.  High-resolution Magnetic Resonance Imaging of Moyamoya Disease.

Authors:  Le-Bao Yu; Qian Zhang; Zhi-Yong Shi; Ming-Qiu Wang; Dong Zhang
Journal:  Chin Med J (Engl)       Date:  2015-12-05       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.